NCT06660459

Brief Summary

To Evaluate Causes of Menorrhagia in Adolescent FemalesSpecially Hematological causes to help in management of abnormal uterine bleeding.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Oct 2024

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 20, 2024

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

October 24, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 28, 2024

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 20, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 20, 2025

Completed
Last Updated

October 28, 2024

Status Verified

October 1, 2024

Enrollment Period

1 year

First QC Date

October 24, 2024

Last Update Submit

October 24, 2024

Conditions

Keywords

Menorrhagia

Outcome Measures

Primary Outcomes (1)

  • Evalution Causes of Menorrhagia in Adolescent FemalesSpecially Hematological causes to help in management

    Evalution Causes of Menorrhagia in Adolescent Females Specially Hematological causes to help in management

    Baseline

Eligibility Criteria

Age8 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Female from age 8 years to age 18 years diseased with menorrhagia and help In dignosis and prevent utrine bleeding

You may qualify if:

  • \- 1. Age of female patients range from (9 -18) years old.
  • \. Girls with heavy menstrual bleeding

You may not qualify if:

  • \. Patients on medication affecting coagulation profile. 2. Patients with pre-existing illness as chronic lung, liver, renal disease or malignancy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (2)

  • ACOG Committee Opinion No. 651: Menstruation in Girls and Adolescents: Using the Menstrual Cycle as a Vital Sign. Obstet Gynecol. 2015 Dec;126(6):e143-e146. doi: 10.1097/AOG.0000000000001215.

  • Barbieri RL. The endocrinology of the menstrual cycle. Methods Mol Biol. 2014;1154:145-69. doi: 10.1007/978-1-4939-0659-8_7.

MeSH Terms

Conditions

Menorrhagia

Condition Hierarchy (Ancestors)

Uterine HemorrhageUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and SymptomsMenstruation Disturbances

Central Study Contacts

Hasnaa Fawzy Abdelbasir Ibrahim., Doctor

CONTACT

Khlid Ibrahim Abdelrahman Elsayh, Doctor

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

October 24, 2024

First Posted

October 28, 2024

Study Start

October 20, 2024

Primary Completion

October 20, 2025

Study Completion

November 20, 2025

Last Updated

October 28, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share